Features the consensus statement issued by the North American Society of
Electrophysiology and Pacing, in conjunction with the American College of Cardiology …

HE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, or T" lCD," is arguably the most
technologically challenging type of therapy that physicians utilize today. At the same time …

Abstract The American College of Cardiology Foundation in collaboration with the Heart
Rhythm Society and key specialty and subspecialty societies conducted a review of common …

Late-breaking clinical trials presented at the annual scientific meetings of the ACC, AHA,
HRS, and European Society of Cardiology (2008 through 2010), as well as other selected …

Multiple randomized multicentre clinical trials have established the role of the implantable
cardioverter-defibrillator (ICD) as the mainstay in the treatment of ventricular …

Life-saving shocks are the raisons d'être of implantable cardioverter-defibrillators (ICDs).
Paradoxically, shocks also cause much of the morbidity associated with ICDs. Consistently …

Importance The US Food and Drug Administration (FDA) evaluates high-risk medical
devices such as cardiac implantable electronic devices (CIEDs), including pacemakers …

OBJECTIVES: The purpose of this study was to (1) determine how often implantable
cardioverter-defibrillator (ICD) system modifications were needed to obtain an adequate …

Objective: To assess the impact of defibrillation threshold (DFT) testing of implanted
cardioverter‐defibrillators (ICDs) on survival. Background: DFT testing is generally …

Aims Ablation of monomorphic ventricular tachycardia (MMVT) has been shown to reduce
shock frequency and improve survival. We aimed to compare cause-specific risk factors for …